Ixekizumab for the treatment of the patients with moderate to severe plaque psoriasis: Clinical data from a real‐world experience
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15955
Abstract: Real‐life data about any particular treatment is very helpful for clinicians, particularly when managing a chronic disease such as psoriasis. In our study, we aimed to reflect our clinical experience during 48 weeks with an IL‐17… read more here.
Keywords: non comorbid; treatment patients; pasi 100; treatment ... See more keywords
The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Public Health"
DOI: 10.3389/fpubh.2023.1000776
Abstract: Introduction Psoriasis is a chronic disease involving the skin, which significantly impacts the quality of life. Disease severity and treatment efficacy (i.e., response) are assessed through the Psoriasis Area and Severity Index (PASI). A PASI… read more here.
Keywords: pasi pasi; pasi response; pasi; pasi 100 ... See more keywords